Abstract:Abstract Humans are frequently exposed to polycyclic aromatic hydrocarbons (PAHs). Cytochrome P4501A (CYP1A) enzymes play important roles in the activation of PAHs such as 3-methylcholanthrene (MC) to DNA-binding metabolites, which in turn mediate carcinogenesis in target organs such as lung, breast, and skin. In this study, we tested the hypothesis that CYP1A1 and 1A2 play mechanistic roles in PAH-mediated carcinogenesis and tumorigenesis. Eight week-old female wild type (WT) (A/J) mice or mice lacking the gene for CYP1A1 or CYP1A2 on the A/J background were treated with a single dose of MC (40 μmol/kg), benzo[a]pyrene (BP), or vehicle (corn oil), and liver and lung tumors were studied after 28 weeks. While 100% of WT or Cyp1a2-null mice exposed to MC showed lung tumors after 28 weeks, about 80% of the Cyp1a1-null mice showed lung tumors. However, there were striking differences in the Cyp1a1-null and Cyp1a2-null mice in regard to lung tumor multiplicities. The WT mice treated with MC had about 15 lung tumors/animal. On the other hand, the Cyp1a2-null mice displayed about 40 lung tumors/animal, while the Cyp1a1-null mice showed about 2-3 tumors/mouse. Although BP was less potent in inducing lung tumors in the WT mice compared to MC, it was similar to MC In that tumors were suppressed in the Cyp1a1-null mice and augmented in the Cyp1a2-null mice. DNA adduct studies at early time points showed increased MC or BP adducts in lungs of Cyp1a2-null mice compared to WT mice, and decreased adduct formation in the Cyp1a1-null mice, supporting the hypothesis that DNA adducts are early biomarkers of PAH-mediated carcinogenesis. Immunohistochemical studies showed that CYP1A1 was overexpressed in the tumorous portions of the lung in the Cyp1a2-null or WT mice, compared to non-tumorous regions. These results suggest that CYP1A1 contributes to the formation of tumorigenesis by PAHs, while CYP1A2 protects against carcinogenesis mediated by PAHs, presumably through it role in PAH detoxification. In conclusion, our results strongly suggest that CYP1A1 and 1A2 could be novel candidates for cancer prevention and therapy though either inhibition of CYP1A1 or induction of CYP1A2. (Supported by NIH grant ES009132.) Citation Format: Bhagavatula Moorthy, Guodong Zhou, Lihua Wang, Weiwu Jiang. Mechanistic roles of cytochrome P4501A1 and 1A2 in lung carcinogenesis mediated by polycyclyc aromatic hydrocarbons: Implications for lung cancer in humans . [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3579. doi:10.1158/1538-7445.AM2013-3579

Effects of 3-Methylcholanthrene on Gene Expression Profiling in the Rat Using Cdna Microarray Analyses

Sustained Induction of CYP1A1 Gene Expression by 3-Methylcholanthrene in Human Hepatoma Cells is Mediated by Persistent Transcriptional Activation of CYP1A1 Promoter

Abstract 825: Molecular Mechanisms of Regulation of Cytochrome P4501A Enzymes by 3-Methylcholanthrene (MC) in Mice in Vivo

Persistent Induction of Hepatic and Pulmonary Phase II Enzymes by 3-Methylcholanthrene in Rats.

Persistent Induction of Cytochrome P450 (CYP)1A Enzymes by 3-Methylcholanthrene in Vivo in Mice is Mediated by Sustained Transcriptional Activation of the Corresponding Promoters

Persistent Induction of Cytochrome P4501a1 in Human Hepatoma Cells by 3-Methylcholanthrene: Evidence for Sustained Transcriptional Activation of the Cyp1a1 Promoter

Molecular Regulation of Hepatic and Pulmonary Cytochrome P4501A (CYP1A1) Enzymes by 3‐methylcholanthrene in Mice: Role of CYP1A2

Abstract 4427: Role of Cytochrome P450 (CYP)1A2 in the Sustained Induction of CYP1A1 by the Carcinogen, 3-Methylcholanthrene (MC) in Mouse Heptoma Cells (Hepa-1)

Abstract 5558: Persistent Induction of Cytochrome P450 (CYP)1A1 in Human Lung Cell Line, H358, by 3-Methylcholanthrene: Implications for Pulmonary Carcinogenesis by Polycyclic Aromatic Hydrocarbons

Abstract 4059: Molecular Role of Cytochrome P450 (CYP)1A2 in the Regulation of Hepatic and Pulmonary CYP1A1 Expression in Mice Exposed to 3-Methycholanthrene

Abstract #1202: Mice Deficient in the Gene for Cytochrome P450 (CYP) 1A1 or 1A2 Display Differential Susceptibilities to CYP1A Induction and Lung Tumorigenesis by 3-Methylcholanthrene (MC)

Mechanistic Role of Cytochrome P450 (cyp)1a2 in the Regulation of Hepatic and Pulmonary Cyp1a1 Expression in Mice Treated with 3-Methycholanthrene

Disruption of the Gene Forcyp1a2, Which is Expressed Primarily in Liver, Leads to Differential Regulation of Hepatic and Pulmonary Mouse CYP1A1 Expression and Augmented Human CYP1A1 Transcriptional Activation in Response to 3-Methylcholanthrene in Vivo

3-Methylcholanthrene-inducible Liver Cytochrome(s) P450 in Female Sprague-Dawley Rats: Possible Link Between P450 Turnover and Formation of DNA Adducts and I-compounds.

3-Methylcholanthrene Elicits DNA Adduct Formation in the CYP1A1 Promoter Region and Attenuates Reporter Gene Expression in Rat H4IIE Cells

Abstract 1587: Mechanistic Role of Cytochrome P4501B1 in DNA Adduct Formation by 3-Methylcholanthrene in Mice: Implications for Lung Cancer in Humans

Polycyclic Aromatic Hydrocarbon-Inducible Dna Adducts: Evidence By P-32-Postlabeling And Use Of Knockout Mice For Ah Receptor-Independent Mechanisms Of Metabolic Activation In Vivo

Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury.

Persistent gene expression and DNA methylation alterations linked to carcinogenic effects of dichloroacetic acid

Abstract 3579: Mechanistic Roles of Cytochrome P4501A1 and 1A2 in Lung Carcinogenesis Mediated by Polycyclyc Aromatic Hydrocarbons: Implications for Lung Cancer in Humans .

DNA methylation and hydroxymethylation associated with gene expression regulatory network during 3-methylcholanthrene induced lung cell malignant transformation